Dr. Jesline Marie Capo , OD
Optometrist β’ Miami, FL
4155 Sw 130th Ave Ste 201
Miami, FL 331753417
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 31, 2023; this date does not establish years in practice.
-
Published CMS data list 221 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Restasis (Cyclosporine) β 114 prescription fills, including refills.
- Latanoprost β 62 prescription fills, including refills.
- Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) β 18 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 5 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under Optometrist in Miami, FL (2024, 103 clinicians with data). Median for this group: 131. Middle half: 24 to 349.
More Part D prescriptions than 60% of clinicians listed under Optometrist in Florida (2024, 1,420 clinicians with data). Median for this group: 123. Middle half: 33 to 409.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 46 in 2023 to 221 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2023β2024.
Practice Location & Contact Primary Location
4155 Sw 130th Ave Ste 201
Miami, FL 331753417
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Optometrist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
254 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$93,312 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $484.34 across 10 records.
By nature of payment
- Food and Beverage: $484.34 across 10 records.
Reporting-company totals (3 largest of 4)
- CooperVision Inc.: $225.92 across 7 records.
- Tarsus Pharmaceuticals, Inc.: $121.87 across 1 record.
- Dompe US, Inc.: $119.70 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2023
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Capo has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Capo as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Miami and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Optometrist in Miami, FL (2024, 103 clinicians with data). Median for this group: 131. Middle half: 24 to 349.
More Part D prescriptions than 60% of clinicians listed under Optometrist in Florida (2024, 1,420 clinicians with data). Median for this group: 123. Middle half: 33 to 409.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Optometrist in Miami, FL (2024, 103 clinicians with data). Median for this group: $13,485. Middle half: $663 to $58,929.
A higher Part D drug cost than 85% of clinicians listed under Optometrist in Florida (2024, 1,420 clinicians with data). Median for this group: $9,998. Middle half: $683 to $49,441.
250 active clinicians are listed under Optometrist with a practice address in Miami, FL (3,613 in Florida).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Miami
2.8% of these 250 clinicians have the CMS telehealth indicator.
35.6% of these 250 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 380% from 46 in 2023 to 221 in 2024.
- 2023: 46
- 2024: 221
-
30-day fills
30-day fills increased 388% from 52 in 2023 to 254 in 2024.
- 2023: 52
- 2024: 254
-
Part D drug cost
Part D drug cost increased 539% from $14,594 in 2023 to $93,312 in 2024.
- 2023: $14,594
- 2024: $93,312
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $106.63 in 2023 to $484.34 in 2025.
- 2023: $106.63
- 2024: $572.76
- 2025: $484.34
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 β December 31, 2025): fewer than 11 records totaling $484.34.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
XDEMVY | General | $121.87 |
| Dompe US, Inc. |
Food and Beverage
In-kind items and services
|
OXERVATE | General | $119.70 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $66.40 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
MyDay Contact Lens | General | $64.26 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $44.22 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $29.10 |
| Bausch & Lomb Americas Inc. |
Food and Beverage
In-kind items and services
|
INFUSE | General | $16.85 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $16.42 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $3.85 |
| CooperVision Inc. |
Food and Beverage
In-kind items and services
|
Clariti Contact Lens | General | $1.67 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Restasis | Cyclosporine | 114 | 3,765 | $79,244.14 | 37 |
| Latanoprost | Latanoprost | 62 | 2,140 | $299.80 | 26 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 18 | 320 | $203.46 | 18 |
| Lumigan | Bimatoprost | 14 | 360 | $3,952.82 | β |
| Restasis Multidose | Cyclosporine | 13 | 432 | $9,611.28 | β |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-05-20NUCC Taxonomy Code: 152W00000X
Doctors of optometry (ODs) are the primary health care professionals for the eye. Optometrists examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. An optometrist has completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. Some optometrists complete an optional residency in a specific area of practice. Optometrists are eye health care professionals state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPTOMETRY
I20230801001620
FL
1355702887
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Optometrist
Doctor of Optometry
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Optometrist (license number reported to NPPES: FL OPC6279)
Optometrist (license number reported to NPPES: FL 6279)
Registered at 4155 SW 130TH AVE STE 201, MIAMI, FL 331753417 (Tel: 3053643737)
Student in an Organized Health Care Education/Training Program
Optometrist (license number reported to NPPES: FL 6279)
NPI status registered as active in NPPES database
Registered at 377 N KROME AVE, HOMESTEAD, FL 330306057 (Tel: 3052473227)
Registered at 5411 SW 87TH AVE, MIAMI, FL 331656738 (Tel: 3057854082)
Recorded as JESLINE CAPO, OD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Optometrists in Miami
- Dr. Janet Castrillo, OD
- Dr. Adriana Carcamo, OD
- Dr. Jessica Pitts, OD
- Dr. Adina Setren-Gould, OD
- Dr. Jessica Lopez, OD
- Dr. Jordan Gott, OD
Mailing Address
5411 Sw 87th Ave
Miami, FL 331656738
Phone: 3057854082